Mega-CV Drops contain a combination of Amoxycillin (80 mg) and Clavulanic Acid (11.4 mg), formulated to provide broad-spectrum antibacterial activity. Amoxycillin, a beta-lactam antibiotic, exerts its effect by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Clavulanic Acid acts as a beta-lactamase inhibitor, preventing enzymatic degradation of Amoxycillin by beta-lactamase-producing bacteria, thereby enhancing its efficacy against resistant strains. This synergistic combination is indicated for the treatment of various infections caused by susceptible organisms, including respiratory tract infections, otitis media, sinusitis, skin and soft tissue infections, and urinary tract infections. Mega-CV Drops are particularly useful in pediatric patients due to their convenient liquid formulation and accurate dosing. The medication should be administered as prescribed, with dosage adjusted according to the severity of infection and patient weight. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and vomiting, as well as hypersensitivity reactions in susceptible individuals. Caution is advised in patients with a history of penicillin allergy or hepatic impairment. Proper adherence to the prescribed regimen is essential to prevent the development of antibiotic resistance. Healthcare professionals should monitor patients for therapeutic response and potential side effects during treatment.